Ryman Healthcare Limited Stock Beta

In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

In accordance with the recently published financial statements, Ryman Healthcare Limited has a Beta of 0.7889. This is 8.27% lower than that of the Healthcare sector and notably higher than that of the Long-Term Care Facilities industry. The beta for all Germany stocks is notably lower than that of the firm.

As returns on the market increase, Ryman Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ryman Healthcare is expected to be smaller as well.

The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Ryman Healthcare financial ratios help investors to determine whether Ryman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.